Financhill
Back

CytomX Therapeutics Quote, Financials, Valuation and Earnings

CytomX Therapeutics Price Quote

$0.89

CytomX Therapeutics Key Stats

Sell
28
CytomX Therapeutics (CTMX) is a Sell

Day range:
$0.86 - $0.90
52-week range:
$0.83 - $5.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.59
P/B ratio:
0%

Volume:
494.7K
Avg. volume:
966.4K
1-year change:
-31.01%
Market cap:
$69.7M
Revenue:
$101.2M
EPS:
$0.17

How Much Does CytomX Therapeutics Make?

Is CytomX Therapeutics Growing As A Company?

  • What Is CytomX Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.27%
  • What Is CytomX Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.75%

CytomX Therapeutics Stock Price Performance

What Is CytomX Therapeutics 52-Week High & Low?

CytomX Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CytomX Therapeutics?

Is CytomX Therapeutics Cash Flow Positive?

  • What Is CTMX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$88.3M
  • What Is CytomX Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.5M
  • What Is CytomX Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $97.4M

CytomX Therapeutics Return On Invested Capital

Data Unavailable

CytomX Therapeutics Earnings Date & Stock Price

CytomX Therapeutics Competitors

CytomX Therapeutics Dividend Yield

CytomX Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 75% 139.37%
Revenue: 26.71% 95.51%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 5.29
Upside from Last Price: 493.93%

Major Shareholders

  • How many CTMX shares are owned by institutional investors?
    66.3M CTMX shares are owned by institutional investors
  • How many CTMX shares are owned by insiders?
    1.7M CTMX shares are owned by insiders